Minimally invasive esophagectomy for benign disease

Area of Science:

• Gastroenterology and Surgical Innovation
• Minimally Invasive Surgery Techniques

Background:

• Minimally invasive esophagectomy (MIE) is recognized for potential benefits like reduced morbidity and quicker recovery in treating benign esophageal conditions.
• However, limited data exists on the long-term efficacy and outcomes of MIE specifically within the context of benign diseases.

Purpose of the Study:

• To evaluate the current understanding and future research directions for minimally invasive esophagectomy (MIE) in the management of benign esophageal conditions.
• To highlight the need for further investigation into the long-term effects and quality-of-life implications of MIE for non-malignant diseases.

Main Methods:

• Review of existing literature and current clinical practice guidelines regarding MIE for benign esophageal diseases.
• Identification of knowledge gaps concerning long-term outcomes and quality of life.

Main Results:

• MIE demonstrates potential for reduced patient morbidity and accelerated recovery in benign conditions.
• Current data on long-term outcomes and quality of life following MIE for benign diseases is scarce.
• Expertise in advanced minimally invasive esophageal surgery and a multidisciplinary team approach are crucial for MIE procedures.

Conclusions:

• MIE is a promising approach for benign conditions, but requires specialized centers and experienced teams.
• Multicenter, prospective randomized controlled trials are essential to compare MIE with open esophagectomy.
• Further research is imperative to establish the long-term benefits and quality-of-life impact of MIE in benign esophageal disease management.